Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression

Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients. Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients. Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients. Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients. Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients. Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Clinical Study on Litozin to be presented at 10th World Congress on Osteoarthritis A poster detailing the effect of Litozin on decreasing cholesterol levels, as well as alleviating symptoms of osteoarthritis will be presented at the Osteoarthritis Research Society International World Congress in Boston, Massachusetts on December 8, 2005. Clinical Study on Litozin to be presented at 10th World Congress on Osteoarthritis A poster detailing the effect of Litozin on decreasing cholesterol levels, as well as alleviating symptoms of osteoarthritis will be presented at the Osteoarthritis Research Society International World Congress in Boston, Massachusetts on December 8, 2005. New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation. New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation. Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit. Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit. Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Study Examines Ability of Vitamin To Help Treatment-resistant Asthma Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Vitamin D Can Play Role in Lung Health study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier. Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier. Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier. Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer. Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). Omega-3 Fatty Acids Can Improve Lung Function Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas. Study Finds Common Supplement Helps To Reduce Cocaine Cravings A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction. Study Finds Common Supplement Helps To Reduce Cocaine Cravings A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction. Study Finds Common Supplement Helps To Reduce Cocaine Cravings A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction. Study Finds Common Supplement Helps To Reduce Cocaine Cravings A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula	LYSAKER, Norway (Dec. 6, 2005) - A new clinical study shows positive effects of Omega-3 Fatty Acids on postpartum depression (1), a common medical condition that affects 10-15 percent of new mothers and can cause serious issues with a woman's mental health. The study, a randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression, was conducted by M.P. Freeman, J.R. Hibbeln, K.L. Wiesner, B.H Brumbacht, M.Watchman, A.J.Gelenberg. The EPAX Omega-3 oil used in the clinical study was provided by Epax AS, the leading supplier of concentrated Omega-3 EPA/DHA fatty acids and previously a division of Pronova Biocare AS. "Omega-3 fatty acids were assessed in a double-blind dose-ranging trial. A combination of Omega-3 EPA and DHA fatty acids provided by EPAX AS was utilized," says Marlene P. Freeman, M.D., director of the Women's Mental Health Program and assistant professor of Psychiatry, Obstetrics & Gynecology, and Nutritional Sciences at the University of Arizona College of Medicine. "Subjects in the trial were randomized to 0.5 g, 1.4 g, or 2.8 g per day (N=16). Among all three doses, patients with postpartum depression improved substantially during the trial. Scores on depression measures decreased by approximately 50 percent, and differences were statistically significant." The Omega-3 fatty acids were well tolerated. In addition, a larger, placebo-controlled trial for perinatal depression is now in progress at the University of Arizona (Marlene P. Freeman, M.D. and colleagues). The knowledge of the health benefits of marine Omega-3 fatty acids is growing worldwide. Scientific evidence continues to mount, representing an opportunity for the treatment and prevention of common diseases. The American Heart Association and the World Health Organization both support the addition of Omega-3 fatty acids to the diet, citing their importance in maintaining good health. About Epax AS: At Epax AS, each production run of Omega-3 carries full quality control documentation to ensure that the highest purity and quality standards are maintained. Chemical analyses take place at every crucial stage and the most stringent, hygienic conditions are applied throughout Epax operations. EPAX products are produced in the cGMP certified state-of-the-art facilities to meet the highest quality standards possible. The products comply with the CRN voluntary monograph and all other known regulations. Epax has gone beyond these standards and recently lowered the limits for all relevant organic pollutants and heavy metals in the product specification to reflect the company¹s commitment to purity. Epax AS is headquartered in Lysaker, Norway and has a GMP approved production facility in Alesund, Norway, which is approved for API production by the Norwegian Board of Health. Epax AS offers concentrated Omega-3 EPA/DHA oils in the business-to-business segment under the brand name EPAX, available in a wide range of top quality formulas with different EPA/DHA ratios focused on specific health conditions. EPAX is also available in TG or EE versions, including TG oils that are available in a deodorized TG/N version, which is virtually without taste and smell. For further information on Epax AS, its products or clinical studies visit www.epax.com or contact Gunilla Traberg at gunilla.traberg@epax.com # # # News Contact: Gunilla Traberg +47 22 53 48 50 gunilla.traberg@epax.com Epax AS P.O. Box 420, N-1327 Lysaker, Norway + 47 22 53 4850 www.epax.com Reference: (1) Freeman MP, Hibbeln JR, Wiesner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-raging pilot trial of Omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2005: 1-5.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software